Published in Korean Diabetes J on February 28, 2010
Retrospective analysis on the efficacy, safety and treatment failure group of sitagliptin for mean 10-month duration. Diabetes Metab J (2011) 0.91
Predicting the DPP-IV inhibitory activity pIC₅₀ based on their physicochemical properties. Biomed Res Int (2013) 0.75
Biology of incretins: GLP-1 and GIP. Gastroenterology (2007) 10.45
Epidemic obesity and type 2 diabetes in Asia. Lancet (2006) 9.54
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes (1995) 8.95
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes (1993) 5.70
Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab (2003) 3.87
NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE. Lancet (1964) 3.41
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia (2007) 3.34
GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab (2006) 3.28
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology (1995) 3.17
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab (2001) 3.09
Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci U S A (1997) 2.42
Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A (1999) 2.29
Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem (1986) 2.22
Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes (2004) 2.17
Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia (2007) 1.97
Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus. Metabolism (2001) 1.83
Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology (1999) 1.74
Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia (2007) 1.73
GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept (2003) 1.70
Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology (1993) 1.68
Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass. Diabetes (2006) 1.45
beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1. Diabetes (2005) 1.41
Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells. Endocrinology (1999) 1.39
Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care (2001) 1.38
Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats. Diabetes (2001) 1.38
Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes (2003) 1.35
Risk factors for the development of NIDDM in Yonchon County, Korea. Diabetes Care (1997) 1.33
On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane. Biochem J (1906) 1.31
Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells. Endocrinology (2008) 1.28
Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes (2001) 1.23
Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. J Clin Invest (1978) 1.22
Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes. Endocr J (2009) 1.18
Impaired beta-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance. Diabetes Res Clin Pract (2003) 1.13
Pancreatic and intestinal processing of proglucagon in man. Diabetologia (1987) 1.13
Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis. Am J Physiol Endocrinol Metab (2003) 1.09
The glucagon-like peptides: pleiotropic regulators of nutrient homeostasis. Ann N Y Acad Sci (2006) 1.07
Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells. Endocrinology (1999) 0.98
Cell-specific expression of glucose-dependent-insulinotropic polypeptide is regulated by the transcription factor PDX-1. Endocrinology (2004) 0.93
On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus. Dan Med Bull (2004) 0.92
A novel mechanism for the suppression of a voltage-gated potassium channel by glucose-dependent insulinotropic polypeptide: protein kinase A-dependent endocytosis. J Biol Chem (2005) 0.90
Redefining the clinical management of type 2 diabetes: matching therapy to pathophysiology. Eur J Clin Invest (2002) 0.88
Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes. Horm Metab Res (2000) 0.85
Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption. Diabetologia (1983) 0.84
WNT/beta-catenin increases the production of incretins by entero-endocrine cells. Diabetologia (2009) 0.84
WNT signalling is both an inducer and effector of glucagon-like peptide-1. Diabetologia (2008) 0.78
Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. Cell Metab (2008) 4.33
Metabolic syndrome and insulin resistance are associated with abnormal left ventricular diastolic function and structure independent of blood pressure and fasting plasma glucose level. Int J Cardiol (2011) 2.11
Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas. Thyroid (2004) 1.56
Prevalence of microalbuminuria and associated risk factors among adult Korean hypertensive patients in a primary care setting. Hypertens Res (2013) 1.52
Chronotropic response to exercise testing is associated with carotid atherosclerosis in healthy middle-aged men. Eur Heart J (2006) 1.46
Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation (2010) 1.44
Exaggerated blood pressure response to exercise is associated with inflammatory markers. J Cardiopulm Rehabil (2006) 1.42
NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci U S A (2007) 1.19
Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db/db mice. Diabetes (2009) 1.17
Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes. J Clin Invest (2014) 1.17
Nuclear factor kappaB protects pancreatic beta-cells from tumor necrosis factor-alpha-mediated apoptosis. Diabetes (2003) 1.14
Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice. Diabetes (2007) 1.10
Bilateral pheochromocytoma associated with paraganglioma and papillary thyroid carcinoma: report of an unusual case. Endocr J (2007) 1.05
Role of hypothalamic proopiomelanocortin neuron autophagy in the control of appetite and leptin response. Endocrinology (2012) 1.04
Inhibition of autoimmune diabetes by TLR2 tolerance. J Immunol (2011) 1.01
Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia: an Asian-Pacific perspective and expert recommendations. Diabetes Res Clin Pract (2011) 0.98
PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells. PLoS One (2013) 0.98
The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population. J Korean Med Sci (2008) 0.97
The inverse association between cardiorespiratory fitness and C-reactive protein is mediated by autonomic function: a possible role of the cholinergic antiinflammatory pathway. Mol Med (2009) 0.97
The Relationship between Lung Function and Metabolic Syndrome in Obese and Non-Obese Korean Adult Males. Korean Diabetes J (2010) 0.96
Efficacy of sitagliptin when added to ongoing therapy in korean subjects with type 2 diabetes mellitus. Diabetes Metab J (2011) 0.93
Selective intra-arterial calcium stimulation with hepatic venous sampling for preoperative localization of insulinomas. Korean J Radiol (2003) 0.92
The favorable outcome of human islet transplantation in Korea: experiences of 10 autologous transplantations. Transplantation (2005) 0.90
Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Int J Cardiol (2013) 0.90
Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Metabolism (2002) 0.89
Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling. J Endocrinol (2014) 0.89
First human trial of pancreatic islet allo-transplantation in Korea--focus on re-transplantation. Diabetes Res Clin Pract (2002) 0.88
Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects. Diabetes Res Clin Pract (2005) 0.88
Apoptosis of human islet cells by cytokines. Immune Netw (2012) 0.88
Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study. Diabetes Care (2012) 0.88
Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans. Int J Cardiol (2009) 0.87
A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise. Diabetes Metab Res Rev (2014) 0.87
A patient with primary squamous cell carcinoma of the thyroid intermingled with follicular thyroid carcinoma that remains alive more than 8 years after diagnosis. Korean J Intern Med (2006) 0.86
The cutoff value of fasting plasma glucose to differentiate frequencies of cardiovascular risk factors in a Korean population. Diabetes Care (2003) 0.86
USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells. Endocr J (2007) 0.86
Metabolic syndrome and cardiovascular diseases in Korea. J Atheroscler Thromb (2014) 0.86
Slow heart rate recovery after exercise is associated with carotid atherosclerosis. Atherosclerosis (2006) 0.85
Exaggerated blood pressure response to exercise is associated with carotid atherosclerosis in apparently healthy men. J Hypertens (2006) 0.85
Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus. Am J Cardiol (2008) 0.84
Effects of activin A on pancreatic ductal cells in streptozotocin-induced diabetic rats. Transplantation (2007) 0.84
Heart rate recovery after exercise and incidence of type 2 diabetes in men. Clin Auton Res (2009) 0.83
RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A. Thyroid (2004) 0.83
Fasting plasma glucose cutoff value for the prediction of future diabetes development: a study of middle-aged Koreans in a health promotion center. J Korean Med Sci (2005) 0.83
Association of metabolic syndrome with microalbuminuria in non-hypertensive type 2 diabetic patients. Nephron Clin Pract (2007) 0.82
Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy. Metabolism (2006) 0.82
Comparisons between macroadenomas and microadenomas in Cushing's disease: characteristics of hormone secretion and clinical outcomes. J Korean Med Sci (2009) 0.81
Activin A, exendin-4, and glucose stimulate differentiation of human pancreatic ductal cells. J Endocrinol (2013) 0.81
Improved outcome of islet transplantation in partially pancreatectomized diabetic mice by inhibition of dipeptidyl peptidase-4 with sitagliptin. Pancreas (2011) 0.81
Relation of heart rate recovery after exercise to C-reactive protein and white blood cell count. Am J Cardiol (2007) 0.81
Troglitazone improves blood flow by inhibiting neointimal formation after balloon injury in Otsuka Long-Evans Tokushima fatty rats. Metabolism (2002) 0.81
Rosiglitazone stimulates the release and synthesis of insulin by enhancing GLUT-2, glucokinase and BETA2/NeuroD expression. Biochem Biophys Res Commun (2008) 0.80
Enhancement of beta-cell regeneration by islet transplantation after partial pancreatectomy in mice. Transplantation (2009) 0.80
Insulin receptor-overexpressing β-cells ameliorate hyperglycemia in diabetic rats through Wnt signaling activation. PLoS One (2013) 0.80
A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes. Endocr J (2015) 0.80
Association between cardiorespiratory fitness and arterial stiffness in men with the metabolic syndrome. Diabetes Res Clin Pract (2010) 0.80
Diabetes-free survival in patients who underwent islet autotransplantation after 50% to 60% distal partial pancreatectomy for benign pancreatic tumors. Transplantation (2013) 0.80
Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients. Diabetes Metab J (2011) 0.80
Association of dietary quality indices with glycemic status in korean patients with type 2 diabetes. Clin Nutr Res (2013) 0.79
Role of JNK activation in pancreatic beta-cell death by streptozotocin. Mol Cell Endocrinol (2010) 0.79
Association between heart rate recovery after exercise testing and plasminogen activator inhibitor 1, tissue plasminogen activator, and fibrinogen in apparently healthy men. Atherosclerosis (2007) 0.79
N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction. Diabetes Res Clin Pract (2007) 0.79
Association between the circulating total osteocalcin level and the development of cardiovascular disease in middle-aged men: a mean 8.7-year longitudinal follow-up study. J Atheroscler Thromb (2014) 0.79
A white blood cell count in the normal concentration range is independently related to cardiorespiratory fitness in apparently healthy Korean men. Metabolism (2005) 0.79
Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients. Metabolism (2008) 0.78
Heterogeneity of early-onset and ketosis-resistant diabetes in Korean subjects--is it possible to determine cut-off age of early-onset type 2 diabetes? Diabetes Res Clin Pract (2005) 0.78
Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma. Endocr J (2014) 0.77
A novel compound heterozygous mutation in the CYP17 (P450 17alpha-hydroxylase) gene leading to 17alpha-hydroxylase/17,20-lyase deficiency. Metabolism (2003) 0.77
Marked suppression of ghrelin concentration by insulin in Prader-willi syndrome. J Korean Med Sci (2007) 0.77
Co-culture with mature islet cells augments the differentiation of insulin-producing cells from pluripotent stem cells. Stem Cell Rev (2015) 0.77
A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors. Clin Transplant (2007) 0.77
Autosomal dominant hypocalcemia caused by an activating mutation of the calcium-sensing receptor gene: the first case report in Korea. J Korean Med Sci (2010) 0.77
Tuberculous encephalopathy without meningitis: pathology and brain MRI findings. Eur Neurol (2011) 0.77
Delayed improvement of insulin secretion after autologous islet transplantation in partially pancreatectomized patients. Metabolism (2009) 0.76
Association between cardiorespiratory fitness and prevalence of carotid atherosclerosis among men with hypertension. Am Heart J (2007) 0.76
The stimulatory effect of IL-1beta on the insulin secretion of rat pancreatic islet is not related with iNOS pathway. Exp Mol Med (2002) 0.76
The ability of β-cells to compensate for insulin resistance is restored with a reduction in excess growth hormone in Korean acromegalic patients. J Korean Med Sci (2012) 0.76
Regulation of glucose control in people with type 2 diabetes: a review and consensus. Korean Diabetes J (2010) 0.75
A case of congenital adrenal hyperplasia mimicking Cushing's syndrome. J Korean Med Sci (2012) 0.75
Cardiac autonomic dysfunction as another missing link between metabolic syndrome and cardiovascular disease. Int J Cardiol (2012) 0.75
Benefits of PEGylation in the early post-transplant period of intraportal islet transplantation as assessed by magnetic resonance imaging of labeled islets. Islets (2014) 0.75
Glucagon/insulin ratio in preoperative screening before pancreatic surgery: correlation with hemoglobin A1C in subjects with and without pancreatic cancer. Endocrine (2014) 0.75
Hippocampal sclerosis and encephalomalacia as prognostic factors of tuberculous meningitis-related and herpes simplex encephalitis-related epilepsy. Seizure (2011) 0.75